ACTIVE_NOT_RECRUITING

Mortality Reductions Based on AUD/Heavy Alcohol Use, HIV Risk, and Cardiovascular Risk

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research study is to investigate if a personalized intervention including parts such as navigation (focus on patient outreach efforts, missed and completed encounters), personalization (individual health benefits) and compensation (value health-related costs borne by patients) will help people reduce their chances of dying from preventable causes, including heart attacks, strokes, drinking alcohol, substance abuse, HIV, and other conditions.

Official Title

Can a Radical Transformation of Preventive Care Reduce Mortality by 20% in Low Socioeconomic (SES) Populations? Preparatory Work Focusing on Alcohol Use Disorder (AUD)/Heavy Alcohol Use, HIV Risk, and Cardiovascular Risk

Quick Facts

Study Start:2024-06-25
Study Completion:2026-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05828849

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:35 Years to 64 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 35 to 64
  2. 2. Low SES (≤ $38,000 annual income, based on 2019 20th percentile NYC income, adjusted for family size)
  3. 3. Expected mortality ≥1% per year (based on age, sex, race/ethnicity), with ≥1 of the following contributors:
  4. 1. 10-year cardiovascular risk ≥10% (assessed by ASCVD risk tool)
  5. 2. Heavy alcohol consumption (defined using SAMHSA binge drinking definition, drinking \>4 standard drinks for men and \>3 standard drinks for women on same occasion in past month)
  6. 4. Willing to be navigated to Health and Hospitals Corporation of New York health system.
  7. 5. Ability to provide written informed consent in English or Spanish
  1. 1. Receives regular care elsewhere than Health and Hospitals Corporation of New York
  2. 2. Already diagnosed with high mortality-condition(s) that are not included in the simulation model.

Contacts and Locations

Principal Investigator

Ronald S Braithwaite, Braithwaite
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYC H+H/Bellevue
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Ronald S Braithwaite, Braithwaite, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-25
Study Completion Date2026-07

Study Record Updates

Study Start Date2024-06-25
Study Completion Date2026-07

Terms related to this study

Additional Relevant MeSH Terms

  • Cardiovascular Disease
  • Alcohol Use Disorder
  • HIV Risk
  • Substance Use Disorders